Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”

Detalles Bibliográficos
Autores principales: Mandt, Stephen R., Gaitonde, Puneet, Ajavon-Hartmann, Antoinette, Klem, Christian, Chan, Anthony, Bastien, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134427/
https://www.ncbi.nlm.nih.gov/pubmed/35603638
http://dx.doi.org/10.1177/10760296221078841
_version_ 1784713775312535552
author Mandt, Stephen R.
Gaitonde, Puneet
Ajavon-Hartmann, Antoinette
Klem, Christian
Chan, Anthony
Bastien, Arnaud
author_facet Mandt, Stephen R.
Gaitonde, Puneet
Ajavon-Hartmann, Antoinette
Klem, Christian
Chan, Anthony
Bastien, Arnaud
author_sort Mandt, Stephen R.
collection PubMed
description
format Online
Article
Text
id pubmed-9134427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-91344272022-05-27 Response to “Critical Analysis of Apixaban Dose Adjustment Criteria” Mandt, Stephen R. Gaitonde, Puneet Ajavon-Hartmann, Antoinette Klem, Christian Chan, Anthony Bastien, Arnaud Clin Appl Thromb Hemost Letter to the Editor SAGE Publications 2022-05-22 /pmc/articles/PMC9134427/ /pubmed/35603638 http://dx.doi.org/10.1177/10760296221078841 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Mandt, Stephen R.
Gaitonde, Puneet
Ajavon-Hartmann, Antoinette
Klem, Christian
Chan, Anthony
Bastien, Arnaud
Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
title Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
title_full Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
title_fullStr Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
title_full_unstemmed Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
title_short Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
title_sort response to “critical analysis of apixaban dose adjustment criteria”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134427/
https://www.ncbi.nlm.nih.gov/pubmed/35603638
http://dx.doi.org/10.1177/10760296221078841
work_keys_str_mv AT mandtstephenr responsetocriticalanalysisofapixabandoseadjustmentcriteria
AT gaitondepuneet responsetocriticalanalysisofapixabandoseadjustmentcriteria
AT ajavonhartmannantoinette responsetocriticalanalysisofapixabandoseadjustmentcriteria
AT klemchristian responsetocriticalanalysisofapixabandoseadjustmentcriteria
AT chananthony responsetocriticalanalysisofapixabandoseadjustmentcriteria
AT bastienarnaud responsetocriticalanalysisofapixabandoseadjustmentcriteria

Ejemplares similares